$CNS

RNS Hotlist with Zak Mir: WNX, CNS, PRE, SWG, THX, JOG, TEK, SVNS, HEX & NEWS

Alliance News says London stocks may open marginally higher as investors watch Strait of Hormuz talks and corporate earnings. Iran and Oman agreed a route and are finalizing joint management, but reopening depends on the US ending Iran port naval blockade. Company updates include WNX selling “Pain Away” to Mentholatum, Corero (CNS) revenue up 42% to $15.5m, PRE receiving $15m of a $165m investment, and TEK reporting H1 net assets $201.7m and profit after tax $144.8m.

Original reporting
Published Aug 6, 2026, 8:31 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 11:30 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
RNS Hotlist with Zak Mir: WNX, CNS, PRE, SWG, THX, JOG, TEK, SVNS, HEX & NEWS — source image
Decision brief

The 30-second read

$CNSBullishMed
01

Why it matters

The newest tradable information is company-specific: binding asset sale (WNX), interim profitability trajectory and contract win (CNS), partial rare-earth project funding with remaining tranche pending (PRE), G-Cloud framework placement (SWG), and drilling/licence/financial updates (THX, JOG, TEK).

02

Market read

Traders can focus on near-term repricing catalysts tied to binding transactions, interim profitability signals, funding progress, and government procurement access, while discounting purely geopolitical background.

03

What to watch

For PRE, the remaining $150m is still outstanding, so schedule risk remains. For CNS, cash balance is down to $2.1m, so investors may scrutinize working-capital needs despite EBITDA improvement.

Relevance 6/10Novelty 6/10Timing: pre-market today, London open set marginally higher as multiple company updates hit

Background

The piece is a multi-name “RNS Hotlist” style roundup, with London set to open marginally higher amid Strait of Hormuz developments and a busy slate of corporate updates.

Company-level read

Ticker impact

$CNSBullishHigh confidence
Context

Corero (CNS) reported H1 revenue up 42% to $15.5m, expects EBITDA of about $2.6m, and cites a notable contract win post-period.

Expected impact

Moderately positive, with potential volatility as investors price in the sustainability of margins and cash burn.

Evidence & confidence

The article provides concrete financial metrics (revenue, EBITDA expectation, cash balance) and explicitly flags a new contract win after the reporting period.

$PRENeutralMedium confidence
Context

Pensana (PRE) said it received $15m to date of a $165m Cascade investment and is securing the remaining $150m for the Longonjo rare earth mine.

Expected impact

Near-term support possible on funding momentum, but upside may be capped until the remaining $150m is secured and timing is clarified.

Evidence & confidence

The article discloses partial receipt and an active effort to secure the remainder, yet it does not confirm when the outstanding funds will arrive or whether delays persist.

Market effects

Cross-currents across small-cap UK sectors: cybersecurity government procurement access (SWG), rare earth project funding (PRE), and gold exploration drilling (THX) all reinforce “pipeline visibility” as a driver.

London small-cap sentiment may improve modestly as several LSE-listed names report discrete catalysts ahead of the open.

Iran-Hormuz route-management headlines are macro/geopolitical background, but the actionable company-specific catalysts dominate the stock-level trading relevance here.

Counterpoint

Framework inclusion (SWG) and drilling headlines (THX) may not translate into near-term cash flows, while valuation-driven jumps (TEK) can unwind if marks prove optimistic.

Key entities

  • Wellnex Life Limited

    Announced a formal binding agreement to sell its “Pain Away” business and assets to Mentholatum Australasia.

  • Corero

    Reported H1 revenue growth, expected EBITDA improvement, and a notable contract win post-period.

  • Pensana

    Discussed Cascade investment funding progress for the Longonjo rare earth mine and the remaining $150m to secure.

  • Shearwater Group

    Secured positions on UK G-Cloud 15 via subsidiaries Brookcourt Solutions and Pentest Limited.

  • Thor Explorations

    Reported diamond drilling intersections of high-grade gold mineralisation open at depth beneath Segilola.

Related articles

$PREMed

Prenetics (PRE) Q2 2026 Earnings Call Transcript

Prenetics (PRE) reported Q2 2026 revenue of $46.5M, up 29% from Q1 and 3.9x from a year ago, with IM8 contributing $45M. The company raised its full-year revenue guidance to $220M-$230M and initiated 2027 guidance of $400M+. July saw record revenue of $20.9M and a 21% drop in customer acquisition cost. PRE expects Q3 to be its first positive cash flow quarter and plans to launch new products in Q4 and Q1 2027.

$PREMed

Prenetics Global Q2 Earnings Call Highlights

Prenetics (NASDAQ:PRE) reported preliminary July revenue of $21.4M, including about $20.9M from IM8, and said it reached its highest monthly level. Q2 added 118,000 new IM8 customers (140,000 active subscribers). Q2 gross profit was $30.2M (65% margin); adjusted EBITDA loss was $19M. It expects H2 2026 adjusted EBITDA loss of $8M to $12M and a first positive quarter on an adjusted free-cash-flow basis with a $1B General Catalyst facility.

$PREHighAI 9/10

Prenetics Global Limited: Prenetics' IM8 Reports Q2 2026 Revenue Growth of 288% YoY; Raises FY 2026 IM8 Revenue Guidance to $220-230 Million; July Was the First Month of Positive Consolidated Adjusted

Prenetics Global (NASDAQ: PRE) reported Q2 2026 revenue of $46.5 million, up about 288% YoY, and IM8 revenue of $45.0 million, up about 359% YoY. Results were within guidance. The company raised FY 2026 total revenue guidance to $220-230 million and initiated FY 2027 IM8 revenue guidance of $400 million+.

$PREMed

PartnerRe records $447m in first-half net income

PartnerRe reported first-half 2026 net income of $447 million, down from $493 million a year earlier, with operating income of $689 million and annualised operating ROE of 12.6%. Gross premiums written rose to $5.42 billion. Non-life underwriting profit was $396 million with a 85.1% combined ratio. Investment income increased to $491 million, but unrealised losses reduced net investment return.

$CNSMed

COHEN & STEERS, INC. (CNS): Results of Operations and Financial Condition

COHEN & STEERS, INC. (CNS) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.2 3 cns-earningsreleasex63026e.htm CNS EARNINGS RELEASE Document COHEN & STEERS REPORTS RESULTS FOR SECOND QUARTER 2026 Strong AUM growth, positive net inflows and continued progress on strategic initiatives • Diluted EPS of $0.95; $0.85, as adjusted • AUM reaches $100.1 bi